UOC
PIII icon

UBS O'Connor’s P3 Health Partners PIII Stock Holding History

UBS O'Connor’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,007
Closed -$5.92M – 991
2021
Q3 		$5.92M Buy
12,007
+4,015
+50% +$1.98M 0.05% 191
2021
Q2 		$3.95M Buy
+7,992
New +$3.92M 0.04% 323

Other funds holding PIII

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

UBS O'Connor's PIII Position: Q4 2021 in Review

UBS O'Connor sold out of P3 Health Partners (PIII) in Q4 2021, closing a stake of 12,007 shares — an estimated $5.92M sold.

UBS O'Connor first reported a position in PIII in Q2 2021 and held it in 2 quarters. The position peaked at $5.92M in Q3 2021. 24 funds tracked by Wall St. Rank hold PIII as of Q4 2021.

  • UBS O'Connor reported no remaining P3 Health Partners position as of Q4 2021 after selling out during the quarter.
  • UBS O'Connor sold 12,007 P3 Health Partners shares in Q4 2021, an estimated $5.92M.
  • UBS O'Connor first reported a position in P3 Health Partners in Q2 2021 and held it in 2 quarters.
  • UBS O'Connor's P3 Health Partners position peaked at $5.92M in Q3 2021.
  • 24 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2021.

Based on UBS O'Connor's 13F filing for Q4 2021, filed 14 Feb 2022.